by The global Veterinary Point Of Care Diagnostics market size is expected to be worth around US$ 5.69 billion by 2030, according to a new report by Vision Research Reports.
The global Veterinary Point Of Care Diagnostics market size was valued at US$ 2.15 billion in 2020 and is anticipated to grow at a CAGR of 12.3% during forecast period 2021 to 2030.
Get Sample Copy of This Report@ https://www.visionresearchreports.com/report/sample/39084
Veterinary Point Of Care Diagnostics Market (By Animal Type: Companion Animals, Livestock Animals; By Product: Consumables, Reagents, & Kits, Instruments & Devices; By Sample Type: Blood/Plasma/Serum, Urine, Fecal; By Testing: Hematology, Diagnostic Imaging, Bacteriology, Virology, Cytology, Clinical Chemistry, Parasitology, Serology; By Indication: Infectious Disease, General Ailments; By End-use: Veterinary Hospitals & Clinics, Home Care Settings) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030
Report Coverage
| Report Scope | Details |
| Market Size | US$ 5.69 billion by 2030 |
| Growth Rate | CAGR of 12.3% From 2021 to 2030 |
| Largest Market | North America |
| Base Year | 2021 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Animal Type, Product, Sample type, Testing category, Indication, End use |
Growth Factors
Technological advancements, strategic initiatives by key market players, rising pet population and humanization, the need to reduce antimicrobial resistance, and the expansion of service offerings by vet clinics are key factors driving the market. Heska, for instance, allocates its R&D budget for developing new Analyzer and Diagnostics Platforms, expanding the menu of analyzer platforms, upgrading the cycle to already installed platforms, and other in-house inventions. The market witnessed a slowdown in sales, reduced demand, and logistical challenges due to the COVID-19 pandemic. The uncertainty was exacerbated by the changing lockdown measures, guidelines on the movement of people and goods, remote work, and self-quarantine conditions.
Several key animal health companies also registered increased profits during 2020. This was owing to the deployment of various strategic initiatives such as diverting their resources to profitable segments to ensure business continuity, acquisitions, and the launch of new products. Heska, for instance, reported 97.4% of growth in its revenue during the first quarter of 2021. IDEXX Laboratories, Inc. reported a 12% increase in year-on-year revenue, driven by the Companion Animal Group (CAG) diagnostics segment, during 2020.
Key Players
- IDEXX Laboratories
- Zoetis
- Virbac
- Heska Corporation
- Thermo Fisher Scientific, Inc.
- Neogen Corporation
- Mindray
- Esaote SpA
- FUJIFILM Corporation
- Woodley Equipment Company Ltd.
Market Segmentation
- By Animal Type
- Companion Animals
- Dogs
- Cats
- Horses
- Others
- Livestock Animals
- Cattle
- Swine
- Poultry
- Others
- Companion Animals
- By Product
- Consumables, Reagents, & Kits
- Instruments & Devices
- By Sample Type
- Blood/Plasma/Serum
- Urine
- Fecal
- Others
- By Testing Category
- Hematology
- Diagnostic Imaging
- Bacteriology
- Virology
- Cytology
- Clinical Chemistry
- Parasitology
- Serology
- Others
- By Indication
- Infectious Disease
- General Ailments
- Others
- By End-use
- Veterinary Hospitals & Clinics
- Home Care Settings
- Others
- Regional
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- MEA
- South Africa
- Saudi Arabia
- Israel
- North America
Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/39084
Reasons to Purchase this Report:
– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Veterinary Point Of Care Diagnostics Market, By Animal Type
7.1. Veterinary Point Of Care Diagnostics Market, by Animal Type, 2021-2030
7.1.1. Companion Animals
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Livestock Animals
7.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Veterinary Point Of Care Diagnostics Market, By Product
8.1. Veterinary Point Of Care Diagnostics Market, by Product, 2021-2030
8.1.1. Consumables, Reagents, & Kits
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Instruments & Devices
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Veterinary Point Of Care Diagnostics Market, By Sample Type
9.1. Veterinary Point Of Care Diagnostics Market, by Sample Type, 2021-2030
9.1.1. Blood/Plasma/Serum
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Urine
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Veterinary Point Of Care Diagnostics Market, By Testing Category
10.1. Veterinary Point Of Care Diagnostics Market, by Testing Category, 2021-2030
10.1.1. Hematology
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Diagnostic Imaging
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Bacteriology
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Virology
10.1.4.1. Market Revenue and Forecast (2017-2030)
10.1.5. Cytology
10.1.5.1. Market Revenue and Forecast (2017-2030)
10.1.6. Virology
10.1.6.1. Market Revenue and Forecast (2017-2030)
10.1.7. Clinical Chemistry
10.1.7.1. Market Revenue and Forecast (2017-2030)
10.1.8. Parasitology
10.1.8.1. Market Revenue and Forecast (2017-2030)
10.1.9. Serology
10.1.9.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Veterinary Point Of Care Diagnostics Market, By Indication
11.1. Veterinary Point Of Care Diagnostics Market, by Indication, 2021-2030
11.1.1. Infectious Disease
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. General Ailments
11.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Veterinary Point Of Care Diagnostics Market, By End-use
12.1. Veterinary Point Of Care Diagnostics Market, by End-use, 2021-2030
12.1.1. Veterinary Hospitals & Clinics
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Home Care Settings
12.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Veterinary Point Of Care Diagnostics Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.1.2. Market Revenue and Forecast, by Product (2017-2030)
13.1.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.1.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.1.5. Market Revenue and Forecast, by Indication (2017-2030)
13.1.6. Market Revenue and Forecast, by End-use (2017-2030)
13.1.7. U.S.
13.1.7.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.1.7.2. Market Revenue and Forecast, by Product (2017-2030)
13.1.7.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.1.7.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.1.7.5. Market Revenue and Forecast, by Indication (2017-2030)
13.1.7.6. Market Revenue and Forecast, by End-use (2017-2030)
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.1.8.2. Market Revenue and Forecast, by Product (2017-2030)
13.1.8.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.1.8.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.1.8.5. Market Revenue and Forecast, by Indication (2017-2030)
13.1.8.6. Market Revenue and Forecast, by End-use (2017-2030)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.2.2. Market Revenue and Forecast, by Product (2017-2030)
13.2.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.2.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.2.5. Market Revenue and Forecast, by Indication (2017-2030)
13.2.6. Market Revenue and Forecast, by End-use (2017-2030)
13.2.7. UK
13.2.7.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.2.7.2. Market Revenue and Forecast, by Product (2017-2030)
13.2.7.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.2.7.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.2.7.5. Market Revenue and Forecast, by Indication (2017-2030)
13.2.7.6. Market Revenue and Forecast, by End-use (2017-2030)
13.2.8. Germany
13.2.8.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.2.8.2. Market Revenue and Forecast, by Product (2017-2030)
13.2.8.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.2.8.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.2.8.5. Market Revenue and Forecast, by Indication (2017-2030)
13.2.8.6. Market Revenue and Forecast, by End-use (2017-2030)
13.2.9. France
13.2.9.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.2.9.2. Market Revenue and Forecast, by Product (2017-2030)
13.2.9.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.2.9.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.2.9.5. Market Revenue and Forecast, by Indication (2017-2030)
13.2.9.6. Market Revenue and Forecast, by End-use (2017-2030)
13.2.10. Rest of Europe
13.2.10.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.2.10.2. Market Revenue and Forecast, by Product (2017-2030)
13.2.10.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.2.10.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.2.10.5. Market Revenue and Forecast, by Indication (2017-2030)
13.2.10.6. Market Revenue and Forecast, by End-use (2017-2030)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.3.2. Market Revenue and Forecast, by Product (2017-2030)
13.3.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.3.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.3.5. Market Revenue and Forecast, by Indication (2017-2030)
13.3.6. Market Revenue and Forecast, by End-use (2017-2030)
13.3.7. India
13.3.7.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.3.7.2. Market Revenue and Forecast, by Product (2017-2030)
13.3.7.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.3.7.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.3.7.5. Market Revenue and Forecast, by Indication (2017-2030)
13.3.7.6. Market Revenue and Forecast, by End-use (2017-2030)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.3.8.2. Market Revenue and Forecast, by Product (2017-2030)
13.3.8.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.3.8.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.3.8.5. Market Revenue and Forecast, by Indication (2017-2030)
13.3.8.6. Market Revenue and Forecast, by End-use (2017-2030)
13.3.9. Japan
13.3.9.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.3.9.2. Market Revenue and Forecast, by Product (2017-2030)
13.3.9.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.3.9.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.3.9.5. Market Revenue and Forecast, by Indication (2017-2030)
13.3.9.6. Market Revenue and Forecast, by End-use (2017-2030)
13.3.10. Rest of APAC
13.3.10.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.3.10.2. Market Revenue and Forecast, by Product (2017-2030)
13.3.10.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.3.10.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.3.10.5. Market Revenue and Forecast, by Indication (2017-2030)
13.3.10.6. Market Revenue and Forecast, by End-use (2017-2030)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.4.2. Market Revenue and Forecast, by Product (2017-2030)
13.4.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.4.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.4.5. Market Revenue and Forecast, by Indication (2017-2030)
13.4.6. Market Revenue and Forecast, by End-use (2017-2030)
13.4.7. GCC
13.4.7.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.4.7.2. Market Revenue and Forecast, by Product (2017-2030)
13.4.7.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.4.7.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.4.7.5. Market Revenue and Forecast, by Indication (2017-2030)
13.4.7.6. Market Revenue and Forecast, by End-use (2017-2030)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.4.8.2. Market Revenue and Forecast, by Product (2017-2030)
13.4.8.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.4.8.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.4.8.5. Market Revenue and Forecast, by Indication (2017-2030)
13.4.8.6. Market Revenue and Forecast, by End-use (2017-2030)
13.4.9. South Africa
13.4.9.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.4.9.2. Market Revenue and Forecast, by Product (2017-2030)
13.4.9.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.4.9.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.4.9.5. Market Revenue and Forecast, by Indication (2017-2030)
13.4.9.6. Market Revenue and Forecast, by End-use (2017-2030)
13.4.10. Rest of MEA
13.4.10.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.4.10.2. Market Revenue and Forecast, by Product (2017-2030)
13.4.10.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.4.10.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.4.10.5. Market Revenue and Forecast, by Indication (2017-2030)
13.4.10.6. Market Revenue and Forecast, by End-use (2017-2030)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.5.2. Market Revenue and Forecast, by Product (2017-2030)
13.5.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.5.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.5.5. Market Revenue and Forecast, by Indication (2017-2030)
13.5.6. Market Revenue and Forecast, by End-use (2017-2030)
13.5.7. Brazil
13.5.7.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.5.7.2. Market Revenue and Forecast, by Product (2017-2030)
13.5.7.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.5.7.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.5.7.5. Market Revenue and Forecast, by Indication (2017-2030)
13.5.7.6. Market Revenue and Forecast, by End-use (2017-2030)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.5.8.2. Market Revenue and Forecast, by Product (2017-2030)
13.5.8.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.5.8.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.5.8.5. Market Revenue and Forecast, by Indication (2017-2030)
13.5.8.6. Market Revenue and Forecast, by End-use (2017-2030)
Chapter 14. Company Profiles
14.1. IDEXX Laboratories
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Zoetis
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Virbac
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Heska Corporation
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Thermo Fisher Scientific, Inc.
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Neogen Corporation
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Mindray
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Esaote SpA
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. FUJIFILM Corporation
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Woodley Equipment Company Ltd.
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/39084
About Us: Our team of skilled and experienced analysts specializes in troubleshooting problems faced by our clients. For comprehensive summary of our services and market research requirements for Global industry.
Contact Us:
call: +1 9197 992 333
Vision Research Report
Any Assistance, Email – sales@visionresearchreports.com
